Sio Gene Therapies Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2017 to Q2 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Sio Gene Therapies Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2017 to Q2 2022.
- Sio Gene Therapies Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2022 was $0.000, a 100% decline year-over-year.
- Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.44M, a 98% decline from 2020.
- Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $73.6M, a 77.5% increase from 2019.
- Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2019 was $41.5M, a 52.4% decline from 2018.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)